40 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound

Must 0 4 12 16 O
be 5 7 17 19 O
able 8 12 20 24 O
to 13 15 25 27 O
stop 16 20 28 32 O
physician 21 30 33 42 O
- 30 31 42 43 O
prescribed 31 41 43 53 O
antihypertensive 42 58 54 70 B-treatment
drug 59 63 71 75 I-treatment
for 64 67 76 79 O
the 68 71 80 83 O
duration 72 80 84 92 O
of 81 83 93 95 O
the 84 87 96 99 O
subject 88 95 100 107 O
's 95 97 107 109 O
participation 98 111 110 123 O
in 112 114 124 126 O
the 115 118 127 130 O
study 119 124 131 136 O
( 125 126 137 138 O
with 126 130 138 142 O
the 131 134 143 146 O
approval 135 143 147 155 O
of 144 146 156 158 O
their 147 152 159 164 O
personal 153 161 165 173 O
physician 162 171 174 183 O
) 171 172 183 184 O

Normotensive 0 12 185 197 B-clinical_variable
< 13 14 198 199 O
120/80 14 20 199 205 B-upper_bound
mmHg 21 25 206 210 I-upper_bound
Hypertensive 26 38 211 223 B-clinical_variable
â‰¥140/90 39 46 224 231 O
mmHg 47 51 232 236 I-lower_bound
and 52 55 237 240 O
< 56 57 241 242 O
160/110 57 64 242 249 B-upper_bound
mmHg 65 69 250 254 I-upper_bound

Subjects 0 8 255 263 O
who 9 12 264 267 O
have 13 17 268 272 O
a 18 19 273 274 O
contraindication 20 36 275 291 O
( 37 38 292 293 O
e.g. 38 42 293 297 O
a 43 44 298 299 O
condition 45 54 300 309 O
, 54 55 309 310 O
medication 56 66 311 321 B-treatment
with 67 71 322 326 O
a 72 73 327 328 O
known 74 79 329 334 O
interaction 80 91 335 346 O
, 91 92 346 347 O
known 93 98 348 353 O
allergy 99 106 354 361 O
) 106 107 361 362 O
to 108 110 363 365 O
only 111 115 366 370 O
one 116 119 371 374 O
or 120 122 375 377 O
two 123 126 378 381 O
of 127 129 382 384 O
the 130 133 385 388 O
three 134 139 389 394 O
pharmacotherapy 140 155 395 410 B-treatment
drugs 156 161 411 416 I-treatment
, 161 162 416 417 O
may 163 166 418 421 O
be 167 169 422 424 O
assigned 170 178 425 433 O
one 179 182 434 437 O
of 183 185 438 440 O
the 186 189 441 444 O
pharmacotherapy 190 205 445 460 O
drugs 206 211 461 466 O
that 212 216 467 471 O
is 217 219 472 474 O
not 220 223 475 478 O
contraindicated 224 239 479 494 O

Women 0 5 495 500 B-gender

Women 0 5 501 506 B-gender
are 6 9 507 510 O
post 10 14 511 515 O
- 14 15 515 516 O
menopausal 15 25 516 526 O
and 26 29 527 530 O
not 30 33 531 534 O
taking 34 40 535 541 O
hormone 41 48 542 549 B-treatment
replacement 49 60 550 561 I-treatment
therapy 61 68 562 569 I-treatment

allergy 0 7 570 577 O
to 8 10 578 580 O
test 11 15 581 585 B-allergy_name
substances 16 26 586 596 I-allergy_name

contraindication 0 16 597 613 O
for 17 20 614 617 O
all 21 24 618 621 B-allergy_name
three 25 30 622 627 I-allergy_name
pharmacotherapy 31 46 628 643 I-allergy_name
drugs 47 52 644 649 I-allergy_name
used 53 57 650 654 I-allergy_name
in 58 60 655 657 I-allergy_name
this 61 65 658 662 I-allergy_name
study 66 71 663 668 I-allergy_name

current 0 7 669 676 O
medications 8 19 677 688 O
which 20 25 689 694 O
could 26 31 695 700 O
conceivably 32 43 701 712 O
alter 44 49 713 718 O
the 50 53 719 722 O
cardiovascular 54 68 723 737 O
or 69 71 738 740 O
thermoregulatory 72 88 741 757 O
control 89 96 758 765 O
or 97 99 766 768 O
responses 100 109 769 778 O
( 110 111 779 780 O
e.g. 111 115 780 784 O
beta 116 120 785 789 B-treatment
blockers 121 129 790 798 I-treatment
, 129 130 798 799 O
calcium 131 138 800 807 B-treatment
channel 139 146 808 815 I-treatment
blockers 147 155 816 824 I-treatment
, 155 156 824 825 O
ACE 157 160 826 829 B-treatment
inhibitors 161 171 830 840 I-treatment
, 171 172 840 841 O
angiotensin 173 184 842 853 B-treatment
receptor 185 193 854 862 I-treatment
blockers 194 202 863 871 I-treatment
) 202 203 871 872 O

diabetes 0 8 873 881 B-chronic_disease

diuretics 0 9 882 891 B-treatment
( 10 11 892 893 O
a 11 12 893 894 O
subject 13 20 895 902 O
taking 21 27 903 909 O
only 28 32 910 914 O
a 33 34 915 916 O
diuretic 35 43 917 925 O
to 44 46 926 928 O
control 47 54 929 936 O
the 55 58 937 940 O
subject 59 66 941 948 O
's 66 68 948 950 O
hypertension 69 81 951 963 B-chronic_disease
may 82 85 964 967 O
be 86 88 968 970 O
included 89 97 971 979 O
in 98 100 980 982 O
the 101 104 983 986 O
study 105 110 987 992 O
if 111 113 993 995 O
the 114 117 996 999 O
subject 118 125 1000 1007 O
stops 126 131 1008 1013 O
taking 132 138 1014 1020 O
the 139 142 1021 1024 O
diuretic 143 151 1025 1033 O
for 152 155 1034 1037 O
the 156 159 1038 1041 O
duration 160 168 1042 1050 O
of 169 171 1051 1053 O
the 172 175 1054 1057 O
subject 176 183 1058 1065 O
's 183 185 1065 1067 O
participation 186 199 1068 1081 O
in 200 202 1082 1084 O
the 203 206 1085 1088 O
study 207 212 1089 1094 O
with 213 217 1095 1099 O
the 218 221 1100 1103 O
approval 222 230 1104 1112 O
of 231 233 1113 1115 O
the 234 237 1116 1119 O
subject 238 245 1120 1127 O
's 245 247 1127 1129 O
personal 248 256 1130 1138 O
physician 257 266 1139 1148 O

history 0 7 1149 1156 O
of 8 10 1157 1159 O
having 11 17 1160 1166 O
taken 18 23 1167 1172 O
an 24 26 1173 1175 O
ACE 27 30 1176 1179 B-treatment
inhibitor 31 40 1180 1189 I-treatment
with 41 45 1190 1194 O
antioxidant 46 57 1195 1206 O
properties 58 68 1207 1217 O
( 69 70 1218 1219 O
e.g. 70 74 1219 1223 O
Captopril 75 84 1224 1233 B-treatment
, 84 85 1233 1234 O
Zofenopril 86 96 1235 1245 B-treatment
) 96 97 1245 1246 O

kidney 0 6 1247 1253 B-chronic_disease
problems 7 15 1254 1262 I-chronic_disease

men 0 3 1263 1266 B-gender

peripheral 0 10 1267 1277 B-chronic_disease
vascular 11 19 1278 1286 I-chronic_disease
disease 20 27 1287 1294 I-chronic_disease

planned 0 7 1295 1302 O
surgery 8 15 1303 1310 B-treatment
requiring 16 25 1311 1320 O
general 26 33 1321 1328 O
anesthesia 34 44 1329 1339 O
during 45 51 1340 1346 O
the 52 55 1347 1350 O
pharmacotherapy 56 71 1351 1366 B-treatment
period 72 78 1367 1373 O

pregnancy 0 9 1374 1383 B-pregnancy

taking 0 6 1384 1390 O
a 7 8 1391 1392 O
diuretic 9 17 1393 1401 B-treatment

